VA Partners With HHS to Fast-Track Veteran Mental Health Care

The federal government just launched its most ambitious effort yet to expand mental health treatment for America's veterans.

The Department of Veterans Affairs and Health and Human Services signed a partnership Monday to accelerate psychedelic therapy research and prepare the VA to deliver these treatments the moment they receive FDA approval. Nearly 6 million veterans live with mental illness or substance use disorders, including about 1 million with serious mental illness.

VA Secretary Doug Collins and HHS Secretary Robert F. Kennedy Jr. signed the five-year agreement at VA headquarters in Washington, implementing a presidential directive to speed new mental health treatments to those who need them most. "These Americans answered our nation's call," Kennedy said during the ceremony. "Now it is our turn to answer theirs."

The partnership tackles a problem that has plagued medical innovation for decades: the gap between scientific discovery and actual patient care. Even after the FDA approves a therapy, it can take years for health systems to train providers and develop protocols to deliver it safely.

The VA isn't waiting. The department is already participating in 20 clinical trials for psychedelic therapies, supported by more than $23 million in funding. Now they're training therapists, nurses, and physicians so the infrastructure exists when approval comes.

Collins explained the urgency to reporters after the signing. "What we don't want is everybody rushing the doors of the VA and we don't have the trained clinical staff to actually carry out the protocols," he said.

The scale of preparation is significant. A single veteran undergoing MDMA-assisted therapy may require more than 100 clinical hours, including preparation sessions, supervised treatment, and follow-up care. That means workforce training matters just as much as the research itself.

Why This Inspires

This partnership represents a fundamental shift in how the federal government approaches mental health innovation. Instead of waiting for treatments to prove themselves and then scrambling to deliver them, agencies are working together to prepare now.

The collaboration establishes data sharing between departments, coordinates clinical trials, and creates educational materials for veterans. When therapies receive approval, the system will be ready.

Kennedy emphasized the administration's commitment to following evidence over politics. "Strong evidence, not ideology or politics, must guide our medical decision making," he said. The trials will determine which therapies work, proper dosages, which patients benefit, and how to deliver treatments safely.

Collins said the VA plans to roll out approved therapies at different locations across the country, ensuring geographic access while maintaining safety and effectiveness. The department is opening training opportunities "as much as we can, as quickly as we can, by training as many clinicians as possible."

For veterans who have exhausted traditional treatment options, this partnership offers something powerful: hope backed by preparation, and the promise that when breakthrough treatments arrive, the wait won't last years.